A cirrhotic patient with ascites has an ascitic fluid white‑cell count of 2.28 × 10⁹/L (≈2 300 cells/mm³) with 69 % neutrophils; what is the diagnosis and how should it be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis: Spontaneous Bacterial Peritonitis (SBP)

This patient has confirmed spontaneous bacterial peritonitis and requires immediate empirical antibiotic therapy with cefotaxime plus intravenous albumin without waiting for culture results. 1, 2

Diagnostic Confirmation

The ascitic fluid analysis definitively establishes SBP:

  • Absolute neutrophil count = 1,573 cells/mm³ (calculated as 2,280 cells/mm³ × 0.69), which far exceeds the diagnostic threshold of ≥250 cells/mm³ 1, 2, 3
  • The neutrophil predominance (69%) with elevated total WBC confirms bacterial peritonitis rather than alternative diagnoses like tuberculous peritonitis (which shows lymphocyte predominance) 2, 4
  • This PMN count yields a positive likelihood ratio of 10.6 for SBP, making the diagnosis essentially certain 1

Critical pitfall to avoid: Do not wait for culture results to initiate treatment—the elevated PMN count alone is sufficient, and each hour of delay increases in-hospital mortality by 3.3% 1, 2

Immediate Management Algorithm

Step 1: Initiate Antibiotics Immediately

First-line therapy: Cefotaxime 2g IV every 8 hours for 5 days 1, 2, 3

  • Alternative regimen: Amoxicillin-clavulanic acid if cefotaxime unavailable 2
  • Do NOT use quinolones if the patient is already on quinolone prophylaxis, in nosocomial SBP, or in areas with high quinolone resistance 2
  • Oral ofloxacin 400mg twice daily may be considered only in uncomplicated cases without vomiting, shock, hepatic encephalopathy ≥grade II, or creatinine >3 mg/dL 2, 3

Step 2: Administer Albumin Therapy

Albumin 1.5 g/kg body weight IV within 6 hours of diagnosis, followed by 1.0 g/kg on day 3 2, 3

  • This regimen reduces mortality from 29% to 10% and decreases type 1 hepatorenal syndrome from 30% to 10% 2, 3
  • Albumin therapy is as essential as antibiotics and should never be omitted 2

Step 3: Obtain Cultures Before Antibiotics

  • Inoculate at least 10 mL of ascitic fluid into aerobic and anaerobic blood culture bottles at bedside before starting antibiotics (increases sensitivity to >90%) 2
  • Obtain simultaneous blood cultures 2
  • However, do not delay antibiotics while waiting for culture bottles—start treatment immediately after paracentesis 1, 2

Step 4: Monitor Treatment Response at 48 Hours

Perform repeat paracentesis at 48 hours to assess treatment efficacy 2

  • Treatment success: PMN count decreases to <25% of pre-treatment value (i.e., <393 cells/mm³ in this case) with clinical improvement 2
  • Treatment failure: PMN count fails to decrease by ≥25% or clinical deterioration persists 1, 2

Step 5: Management of Treatment Failure

If PMN count remains elevated or clinical status worsens at 48 hours:

  • Consider resistant organisms requiring antibiotic modification based on culture sensitivities 2
  • Rule out secondary bacterial peritonitis with CT imaging and surgical consultation 2
  • Secondary peritonitis typically shows ascitic protein >1 g/dL, LDH higher than serum levels, glucose <50 mg/dL, or multiple organisms on Gram stain 2

Additional Diagnostic Considerations

To differentiate SBP from secondary peritonitis, measure:

  • Ascitic fluid total protein, LDH, and glucose 2
  • Perform Gram stain (multiple organisms suggest secondary peritonitis) 2
  • Calculate serum-ascites albumin gradient (SAAG) if not already done 1

Prognosis and Follow-up

  • In-hospital mortality remains approximately 20% despite appropriate treatment 1, 2
  • One-year survival after SBP hospitalization is only 34% 1
  • All patients recovering from SBP should be evaluated for liver transplantation if not already assessed 1
  • Secondary prophylaxis with norfloxacin or trimethoprim-sulfamethoxazole should be initiated after resolution to prevent recurrence 1

Common pitfall: Culture-negative neutrocytic ascites (PMN >250/mm³ with negative culture) has identical morbidity and mortality to culture-positive SBP and must be treated identically 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Treatment of Spontaneous Bacterial Peritonitis (SBP)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Management of Spontaneous Bacterial Peritonitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach to High Lymphocyte Percentage in Peritoneal Fluid

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What does a mononuclear predominance in ascitic fluid analysis indicate, and is it associated with infection?
Can Chinese ink be used in ascitic fluid for diagnostic purposes?
How to diagnose Spontaneous Bacterial Peritonitis (SBP) in ascitic fluid?
What are the criteria for Gas and Acid (GASA) analysis of peritoneal fluid?
What are the WBC (white blood cell) count criteria for diagnosing spontaneous bacterial peritonitis (SBP)?
Can you provide dosing, administration, monitoring, adverse effects, contraindications, and alternative agents for tacrolimus (including oral use in adult solid‑organ transplantation and topical use in atopic dermatitis)?
Is venlafaxine (Effexor) appropriate for treating depression, anxiety, or agitation in a patient with frontotemporal (frontal‑lobe) dementia?
What oral antibiotics and dosing are appropriate for an adult with chronic kidney disease who has uncomplicated cellulitis and can be managed as an outpatient?
What is the first‑line treatment for a newly diagnosed adult with type 2 diabetes without cardiovascular disease, heart failure, or chronic kidney disease?
Should I prescribe digoxin 0.25 mg orally once daily for a patient with systolic heart failure or atrial fibrillation who has reduced renal function and low potassium?
Can an adult patient with a diagnosed sleep‑wake disorder (e.g., narcolepsy, obstructive sleep‑apnea‑related excessive daytime sleepiness, or shift‑work disorder) and no contraindications safely take 200 mg of modafinil daily?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.